The nearest likely catalyst is longhaulers results. From the results we have from the 4 patients that have went public they should be very good. With the large activist longhaulers population word will spread like wildfire and the larger phase 3 should fill very fast. Very good chance we can get results on phase 3 before the end of the year.

Before then we may get some ancedotal results out of the Philippines and India and even sales out of the Philippines but I don't think those are going to move any mountains.

Next big catalyst of course Brazil interim results.

Possible BTD for cancer but I wouldn't trust the FDA on that one no matter how good the results.

I wouldn't doubt that the FDA screws us on the combo BLA again. Nader just needs to get the mono protocol approved and start that trial now.